Skip to main content

Advertisement

SpringerLink
Log in

Physicochemical and pharmacokinetic evaluation of rosuvastatin loaded nanostructured lipid carriers: influence of long- and medium-chain fatty acid mixture

  • Original Article
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Combination of long and medium chain lipids show different behavior in-vivo and contribute differently for bioavailability. Aim of the present study was to evaluate the effect of long chain- (LCFA) and medium-chain (MCFA) fatty acid lipids on the bioavailability of rosuvastatin from rosuvastatin loaded nanostructured lipid carrier (RNLC). Lauric acid and capryol-90™ were selected as MCFA whereas stearic acid and oleic acid were chosen as LCFA. RNLC was prepared using melt-emulsification–ultrasonication method using different combinations of MCFA and LCFA. Non-ionic, non-toxic MYS-25 was used as stabilizing agent. RNLC showed entrapment efficiency of 85–92% denoting it to be beneficial for prolonged release of drug after oral administration. Zeta potential of −26.79 mV signifies particle stability through the repulsive forces which prevents aggregation upon storage. In-vivo oral pharmacokinetic study demonstrated six to ninefold improvement in the bioavailability of rosuvastatin (RSVS) in the form of RNLC than RSVS-Aqueous dispersion. A 1.5-fold increase in bioavailability was observed when RNLC was prepared with LCFA solid lipid and MCFA liquid lipid combination as compared to RNLC prepared using only MCFA as both solid and liquid lipid. Use of LCFA and MCFA combination was found to be superior as lipid mixture for the RNLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Chakraborty S, Shukla D, Mishra B, Singh S (2009) Lipid—an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm 73:1–15

    Article  PubMed  CAS  Google Scholar 

  • Chen CC, Tsai TH, Huang ZR, Fang JY (2010) Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm 74:474–482

    Article  PubMed  CAS  Google Scholar 

  • Chormale SB, Vavia PR (2012) Development and evaluation of stable solid self-micro emulsifying drug delivery system of rosuvastatin. IPC 64th 2012

  • Chougule M, Padhi, Misra A (2007) Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics. Int J Nanomed 2:675–688

    CAS  Google Scholar 

  • Clark AM, Jepson MA, Hirst BH (2001) Exploiting M cells for drug and vaccine delivery. Adv Drug Deliv Rev 50:81–106

    Article  PubMed  CAS  Google Scholar 

  • Costa P, Lobo JMS (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13:123–133

    Article  PubMed  CAS  Google Scholar 

  • Devani M, Ashford M, Craig DQ (2004) The emulsification and solubilisation properties of polyglycolysed oils in self-emulsifying formulations. J Pharm Pharmacol 56:307–316

    Article  PubMed  CAS  Google Scholar 

  • Gershanik T, Benita S (2000) Self-dispersing lipid formulations for improving oral absorption of lipophillic drugs. Eur J Pharm Biopharm 50:179–188

    Article  PubMed  CAS  Google Scholar 

  • Grove M, Mullertz A, Nielsen JL, Pedersen GP (2006) Bioavailability of seocalcitol II: development and characterization of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Eur J Pharm Sci 28:233–242

    Article  PubMed  CAS  Google Scholar 

  • Hac-Wydro K, Wydro P (2007) The influence of fatty acids on model cholesterol/phospholipid membranes. Chem Phys Lipids 150:66–81

    Article  PubMed  CAS  Google Scholar 

  • Han S, Yao T, Zhang X, Gan L, Zhu C, Yu H, Gan Y (2009a) Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation. Int J Pharm 379:18–24

    Article  PubMed  CAS  Google Scholar 

  • Han HF, Yao TT, Zhang XX, Gan L, Zhu C, Yu HZ, Gan Y (2009b) Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation. Int J Pharm 379:18–24

    Article  PubMed  CAS  Google Scholar 

  • Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA, Keirns JJ (1998) Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci 87:164–169

    Article  PubMed  CAS  Google Scholar 

  • Honary S, Zahir F (2013) Effect of zeta potential on the properties of nano-drug delivery systems—a review (Part 2). Trop J Pharm Res 12:265–273

    Google Scholar 

  • http://www.acessdata.fda.gov/drugsatfda_docs/nda/2013/21-366_Pharmr_P1.pdf. Accessed on 10 May 2017

  • Hussain N, Jaitley V, Florence AT (2001) Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev 50:107–142

    Article  PubMed  CAS  Google Scholar 

  • Jantratid E, Janssen N, Reppas C, Dressman JB (2008) Dissolution media simulating conditions in the proximal human git: an update. Pharm Res 25(7):1663–1676

    Article  PubMed  CAS  Google Scholar 

  • Jia LJ, Zhang DR, Li ZY, Duan CX, Wang YC, Feng FF, Wang FH, Liu Y, Zhang Q (2010) Nanostructured lipid carriers for parenteral delivery of silybin: biodistribution and pharmacokinetic studies. Colloids Surf B 80:213–218

    Article  CAS  Google Scholar 

  • Khoo S, Humberstone AJ, Christopher JHP, Edwards GA, Charman WN (1998) Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm 167:155–164

    Article  CAS  Google Scholar 

  • Kumar TR, Shitut NR, Kumar PK, Vinu MC, Kumar VV, Mullangi R, Srinivas NR (2006) Determination of rosuvastatin in rat plasma by HPLC: validation and its application to pharmacokinetic studies. Biomed Chromatogr 20:881–887

    Article  PubMed  CAS  Google Scholar 

  • Kumbhar DD, Pokharkar VB (2013) Engineering of nanostructured lipid carrier of the poorly water-soluble drug, bicalutamide: physicochemical investigations. Colloids Surf A 416:32–42

    Article  CAS  Google Scholar 

  • Kuo YC, Chung JF (2011) Physicochemical properties of nevirapine loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf B 83:299–306

    Article  CAS  Google Scholar 

  • Lennernas H (1998) Human intestinal permeability. J Pharm Sci 87:403–410

    Article  PubMed  CAS  Google Scholar 

  • Li X, Nie SF, Kong J, Li N, Ju CY, Pan WS (2008) A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 363:177–182

    Article  PubMed  CAS  Google Scholar 

  • Li X, Gu L, Xu Y, Wang Y (2009) Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats. Drug Dev Ind Pharm 35:827–833

    Article  PubMed  CAS  Google Scholar 

  • Liu DH, Liu ZH, Wang LL, Zhang C, Zhang N (2011) Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B 85:262–269

    Article  CAS  Google Scholar 

  • Luo Y, Chen D, Ren L, Zhao X, Qin J (2006) Solid lipid nanoparticles for enhancing vinpocetine’s oral bioavailability. J Control Release 114:53–59

    Article  PubMed  CAS  Google Scholar 

  • Majumdar S, Mitra A (2006) Chemical modification and formulation approaches to elevated drug transport across cell membranes. Expert Opin Drug Deliv 3:511–527

    Article  PubMed  CAS  Google Scholar 

  • Matulka RA, Thompson DV, Burdock GA (2009) Lack of toxicity by medium chain triglycerides (MCT) in canines during a 90-day feeding study. Food Chem Toxicol 47:35–39

    Article  PubMed  CAS  Google Scholar 

  • Mehnert W, Mäder K (2001) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliver Rev 47:165–196

    Article  CAS  Google Scholar 

  • Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur J Pharm Biopharm 50:161–177

    Article  PubMed  Google Scholar 

  • Müller RH, Radtke M, Wissing SA (2002) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242:121–128

    Article  PubMed  Google Scholar 

  • Ochiai A, Ohkuma M, Danjo K (2012) Investigation of surfactants suitable for stabilizing of latanoprost. Int J Pharm 436:732–737

    Article  PubMed  CAS  Google Scholar 

  • Odeberg JM, Kaufmann P, Kroon KG, Höglund P (2003) Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability applied to cyclosporine. Eur J Pharm Sci 20:375–382

    Article  PubMed  CAS  Google Scholar 

  • Pardeike J, Webera S, Haber T, Wagner J, Zarfl HP, Plank H, Zimmer A (2011) Development of an Itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application. Int J Pharm 419:329–338

    Article  PubMed  CAS  Google Scholar 

  • Patel BZ, Patel KS, Shah AS, Surti NI (2012) Preparation and optimization of microemulsion of rosuvastatin calcium. J Pharmacy Bioallied Sci 4:S118–S119

    Google Scholar 

  • Ruan LP, Chen S, Yu BY, Zhu DN, Cordell GA, Qiu SX (2006) Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur J Med Chem 41:605–610

    Article  PubMed  CAS  Google Scholar 

  • Ruckenstein E, Shulgin I (2005) Solubility of drugs in aqueous solutions Part 5, Thermodynamic consistency tests for the solubility data. Int J Pharm 292:87–94

    Article  PubMed  CAS  Google Scholar 

  • Song KH, Chung SJ, Shim CK (2005) Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Rel 106:298–308

    Article  CAS  Google Scholar 

  • Ton MN, Chang C, Carpentier YA, Deckelbaum RJ (2005) In vivo and in vitro properties of an intravenous lipid emulsion containing only medium chain and fish oil triglycerides. Clin Nutr 24:492–501

    Article  PubMed  CAS  Google Scholar 

  • Trevaskis NL, Charman WN, Porter CJH (2008) Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 60:702–716

    Article  PubMed  CAS  Google Scholar 

  • Tsai MJ, Wu PC, Huang YB, Chang JS, Lin CL, Tsai YH, Fang JY (2012) Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int J Pharm 423:461–470

    Article  PubMed  CAS  Google Scholar 

  • Venkatesan N, Uchino K, Amagase K, Ito Y, Shibata N, Takada K (2006) Gastrointestinal patch system for the delivery of erythropoietin. J Control Rel 111:19–26

    Article  CAS  Google Scholar 

  • Zheng M, Falkeborg M, Zheng Y, Yang T, Xua X (2013) Formulation and characterization of nanostructured lipid carriers containing a mixed lipids core. Colloids Surf A 430:76–84

    Article  CAS  Google Scholar 

  • Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, Pan YS, Tang X (2010) Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 394:179–185

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune, Maharashtra, 411038, India

    Varsha Pokharkar, Arpana Patil-Gadhe & Gursheen Kaur

Authors
  1. Varsha Pokharkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arpana Patil-Gadhe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gursheen Kaur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Varsha Pokharkar.

Ethics declarations

Conflict of interest

The authors report no declaration of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pokharkar, V., Patil-Gadhe, A. & Kaur, G. Physicochemical and pharmacokinetic evaluation of rosuvastatin loaded nanostructured lipid carriers: influence of long- and medium-chain fatty acid mixture. J. Pharm. Investig. 48, 465–476 (2018). https://doi.org/10.1007/s40005-017-0342-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-017-0342-8

Keywords

Search

Navigation